Navigation Links
Quality Standards Established for Competition to Identify Best Researchers in the US

LONDON, April 17, 2012 /PRNewswire/ --

Senior clinical executives from top pharmaceutical companies, including AstraZeneca, Sanofi, Shire and GSK, met recently at the US offices of Shire Pharmaceuticals to agree quality standards and define competencies for a global competition to recognise and encourage talented researchers in North and South America.

The US Clinical Researcher of the Year competition ( provides professionals working within the clinical research fraternity an opportunity for personal development through a series of peer-mediated, competency-based exercises. It is partnered with and sponsored by the ACRP.

"There are very few opportunities for professionals to benchmark their skills within a protected environment, where the quality standards are established and judged by senior industry peers," notes Sean Morgan-Jones of organizers PharmaTimes. "The aims of the competition are three-fold. To provide a development opportunity for ambitious research professionals, to help organizations benchmark with their peers, and to deliver industry insights and learning."

Themes identified by the competition's Executive Steering Committee for the 2012 competition include risk-based monitoring and technology as a facilitator for patient recruitment. The committee's first task was to agree quality standards for the first phase of the competition, an online multiple-choice questionnaire based on ICH/GCP/FDA regulatory guidelines and ratified by lead examiners from ACRP. Susan Romberg, vice president of clinical operations for the Americas at competition sponsors PRA, is leading a sub-committee to develop the case study used in the second screening stages.

This year the qualifying score has been raised to 80%.

The finals and awards are on November 8, 2012, at the Executive Briefing Centre of competition sponsors and hosts, SAS, in Cary, North Carolina.

Up to 10 finalists will compete head to head for six titles, Study Nurse (working at the investigator site), New CRA (less than four years' experience), Experienced CRA (more than four years' experience), Trial Manager (working with a sponsor company), Project Manager (working within a CRO) and Clinical Research Team.

Jo West, from PRA and winner of the CRA category last year, commented: "This is a first class competition. I was challenged and exhilarated from the time of entering through to the awards evening. I would encourage all individuals to enter the competition to reinforce and build their confidence and knowledge to further their careers."

Entry is open for the 2012 US Clinical Researcher of the Year Competition. Go to or email or call +44-208-8788566

SOURCE Pharma Times
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
2. AMPAC Fine Chemicals Continues to Invest in Quality Systems
3. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
4. New Resource Provides Herb Industry With Sources of Quality Specifications
5. Establishing the Correct QbD Strategies and Tools Early in the Development Process is Key to Ensuring we Have Robust Quality Products Downstream
6. Controlling silicon evaporation allows scientists to boost graphene quality
7. Clinical Integration Enables Leading Health Systems to Deliver Higher Quality, Cost-Effective Care
8. New Study Finds Cord Blood-derived Stem Cell Treatments Improve Ataxia Patients Functionality and Quality of Life
9. PrimeraDx Names Fayyaz Memon Vice President of Regulatory Affairs and Quality Assurance
10. Elsevier Strikes Exclusive eLearning Partnership with The Quality Group
11. ACO Proposed Rule: Nine out of Ten Quality Measures Mirror Other Quality Reporting Programs
Post Your Comments:
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
Breaking Biology News(10 mins):